127 related articles for article (PubMed ID: 15913616)
1. Endometrial adenocarcinoma after prolonged tibolone therapy.
Nassar AH; Khalil AM; Seoud MA; Usta IM
Int J Gynaecol Obstet; 2005 Jul; 90(1):78-9. PubMed ID: 15913616
[No Abstract] [Full Text] [Related]
2. Endometrial cancer--surprising reports.
Speroff L
Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
[No Abstract] [Full Text] [Related]
3. Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.
Perez-Medina T; Bajo-Arenas J; Haya J; Sanfrutos L; Iniesta S; Bueno B; Castelo-Branco C
Menopause; 2003; 10(6):534-7. PubMed ID: 14627862
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma of the endometrium in patients treated with tibolone.
Yazigi R; Sahid S; Contreras L; Rodriguez T
Gynecol Oncol; 2004 May; 93(2):568-70. PubMed ID: 15099984
[TBL] [Abstract][Full Text] [Related]
5. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.
Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC
Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483
[TBL] [Abstract][Full Text] [Related]
6. Case-series report: management of post-menopausal bleeding in the presence of an intrauterine device.
Pisal N; Mammo M
Contraception; 2002 Nov; 66(5):383-4. PubMed ID: 12443971
[TBL] [Abstract][Full Text] [Related]
7. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
Eilertsen AL; Liestøl S; Mowinckel MC; Hemker HC; Sandset PM
Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
[TBL] [Abstract][Full Text] [Related]
8. The LIBERATE tibolone trial in breast cancer survivors.
Speroff L
Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
[No Abstract] [Full Text] [Related]
9. Endometrial metastases from gastric adenocarcinoma: a case report.
Pasini A; Mandelli P; Belloni C
Tumori; 1995; 81(5):383-6. PubMed ID: 8804459
[TBL] [Abstract][Full Text] [Related]
10. A case report of recurrent endometriosis following Tibolone hormone replacement therapy.
Sundar SS; Gornall RJ; Kerr-Wilson R; Swingler GR; Kinder RB; McCarthy K
J Obstet Gynaecol; 2007 May; 27(4):433-4. PubMed ID: 17654209
[No Abstract] [Full Text] [Related]
11. Endometrial cancer and hormone-replacement therapy.
Wiegratz I; Kuhl H
Lancet; 2005 Jul 16-22; 366(9481):201-2. PubMed ID: 16023504
[No Abstract] [Full Text] [Related]
12. Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
von Dadelszen P; Gillmer MD; Gray MD; McEwan HP; Pyper RJ; Rollason TP; Wright A
Br J Obstet Gynaecol; 1994 Feb; 101(2):158-61. PubMed ID: 8305393
[No Abstract] [Full Text] [Related]
13. The Million Women Study--is it believable?
Farmer R
Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
[No Abstract] [Full Text] [Related]
14. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
Biglia N; Maffei S; Lello S; Nappi RE
Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
[TBL] [Abstract][Full Text] [Related]
15. [The influence of a tibolone therapy on endometrium in postmenopausal women].
Szlendak-Sauer K; Wierzba W; Radowicki S
Ginekol Pol; 2008 Nov; 79(11):758-61. PubMed ID: 19140498
[TBL] [Abstract][Full Text] [Related]
16. [Tibolone therapy in postmenopausal women with a history of many risk factors].
Szántó F
Orv Hetil; 2003 Apr; 144(15):701-4. PubMed ID: 12774429
[TBL] [Abstract][Full Text] [Related]
17. Clinical inquiries. What is the best diagnostic approach to postmenopausal vaginal bleeding in women taking hormone replacement therapy?
Kerns JW; Mabry S; Lopez R
J Fam Pract; 2001 Oct; 50(10):843-4. PubMed ID: 11674884
[No Abstract] [Full Text] [Related]
18. Bleeding with menopausal hormone therapy.
Hickey M; Agarwal S
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):141-9. PubMed ID: 18977184
[TBL] [Abstract][Full Text] [Related]
19. Natural history of endometrial cancer: report of one woman who did not accept treatment.
Norström A; Granberg S
Acta Obstet Gynecol Scand; 2004 May; 83(5):506-7. PubMed ID: 15059170
[No Abstract] [Full Text] [Related]
20. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
Lyytinen H; Ylikorkala O
Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
